Epidermal Growth Factor Receptor Mutation in Resectable Lung Cancer: Association With Survival Outcomes.

Ann Thorac Surg Short Rep · 2026 · PMC13100781 · PMID 42027539

Europe PMC DOI

hedged sentences

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a nonsignificant trendP = .12not close (p > 0.1)

This difference was statistically significant in stage II ( P = .046), while a nonsignificant trend favoring EGFRmu was observed in stage IA ( P = .12; Supplemental Figure 4 ).

also in 5,406 other papers

a small trendno p-value reported

When stratified by stage, there were stark survival differences in stage IB and a small trend in stage IA patients that could be explained by the fact that EGFRwt patients include a large subset of NSCLC cases characterized by KRAS mutations.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.